The efficacy of BCG has also been hypothesized to involve IL-17 secreting Ag-specific CD4+ T cells (Th17) cells in lung [27,28], and expansion of Th17 cells in lung has been linked to improved vaccine-outcomes for experimental TB vaccines [29,30]. This evidence concerns the gene CD4 and tuberculosis.